Leigh Borstein Lurie, MD | |
15001 Shady Grove Rd Ste 300, Rockville, MD 20850-6353 | |
(301) 340-3252 | |
(301) 340-1423 |
Full Name | Leigh Borstein Lurie |
---|---|
Gender | Female |
Speciality | Gastroenterology |
Experience | 17 Years |
Location | 15001 Shady Grove Rd Ste 300, Rockville, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427225887 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | D72288 (Maryland) | Primary |
207R00000X | Internal Medicine | 0101247785 (Virginia) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Adventist Healthcare Shady Grove Medical Center | Rockville, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Capital Digestive Care Llc | 3870669419 | 196 |
News Archive
Researchers in Sweden have shown how data-driven AI could contribute to a better understanding of how prostate cancer develops, and even improve clinical diagnosis and treatment of the disease.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Berlin, Germany from November 16 to19, 2010.
Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience.
A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.
› Verified 4 days ago
Entity Name | Capital Digestive Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164683181 PECOS PAC ID: 3870669419 Enrollment ID: O20080905000450 |
News Archive
Researchers in Sweden have shown how data-driven AI could contribute to a better understanding of how prostate cancer develops, and even improve clinical diagnosis and treatment of the disease.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Berlin, Germany from November 16 to19, 2010.
Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience.
A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Leigh Borstein Lurie, MD 10770 Columbia Pike Ste 400, Silver Spring, MD 20901-4462 Ph: (215) 589-9012 | Leigh Borstein Lurie, MD 15001 Shady Grove Rd Ste 300, Rockville, MD 20850-6353 Ph: (301) 340-3252 |
News Archive
Researchers in Sweden have shown how data-driven AI could contribute to a better understanding of how prostate cancer develops, and even improve clinical diagnosis and treatment of the disease.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Berlin, Germany from November 16 to19, 2010.
Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience.
A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.
› Verified 4 days ago
Dr. Sheila Gay Levin, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 14955 Shady Grove Rd, Suite 150, Rockville, MD 20850 Phone: 301-340-3252 Fax: 301-340-1423 | |
Dr. Shubir Sofat, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10110 Molecular Dr Ste 200, Rockville, MD 20850 Phone: 301-610-4000 Fax: 301-610-4007 | |
Dr. Kajal Dasgupta, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2101 E Jefferson St, Kaiser Permanente Medicare Enrollment, Rockville, MD 20852 Phone: 301-816-2424 | |
Joseph M Haggerty, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9707 Medical Center Dr, Suite 300, Rockville, MD 20850 Phone: 301-424-6231 Fax: 301-294-4648 | |
Isabelle A Hertig, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11125 Rockville Pike, Suite 208, Rockville, MD 20852 Phone: 301-881-5858 Fax: 301-260-2838 | |
Dr. Wellington Sun, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1401 Rockville Pike, Suite 300n, Rockville, MD 20852 Phone: 301-827-3070 Fax: 301-827-3532 | |
Dr. Wei Fan, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2401 Research Blvd Ste 370, Rockville, MD 20850 Phone: 240-690-4114 Fax: 240-654-3915 |